Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable

Abstract

Multiple sclerosis is a heterogeneous disease with varying clinical picture. There have been substantial efforts to develop outcome measurements for therapeutic interventions but very few studies have addressed the value of bodily functions from the patient perspective. In a randomly selected cohort of early (<5 years, n = 84) and longer lasting disease courses (>15 years, n = 82) patients we asked for a weighting of 13 bodily functions and compared results with actual disability as measured by the United Kingdom Disability Scale. Lower limb function was given the highest priority in both patient groups followed by visual functioning and cognition especially in longer lasting MS. Actual disability did not correlate with the given priorities indicating that experienced deficits do not influence the subjective ratings of bodily functions. These results underline that ambulation-focused scales in MS represent a key dimension from the patient perspective. Visual functioning should be taken more into account.

Keywords

multiple sclerosis outcome scale perception of bodily functions United Kingdom Disability Scale

Get full access to this article

View all access options for this article.

References

1 Sharrack B Hughes RAC Soundain S Dunn G . The psychometric properties of clinical rating scales used in multiple sclerosis. Brain 1999; 122: 141–145.

2 Thompson AJ Hobart JC . Multiple sclerosis: assessment of disability and disability scales. J Neurol 1998; 245: 189–196.

3 Rudick R Antel J Confavreux C Cutter G Ellison G Fischer J . Clinical outcomes assessment in multiple sclerosis. Ann Neurol 1996; 40: 469–479.

4 Mitchell AJ Benito-Leon J Gonzalez JM Rivera-Navarro J . Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing. Lancet Neurol 2005; 4: 556–566.

5 Rothwell PM McDowell JD Wong CK Dorman PJ . Doctors and patients don’t agree: cross sectional study of patients’ and doctors’ perceptions and assessments of disability in multiple sclerosis. BMJ 1997; 314: 1580–1583.

6 Poser CM Paty CDW Scheinberg L . New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227–231.

7 Heesen C Kasper J Segal J Koepke S Mühlhauser I . Decisional role preferences, knowledge and information interests in patients with multiple sclerosis. Mult Scler 2004; 10: 643–650.

8 Sharrack B Hughes RAC . The Guy’s Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis. Mult Scler 1999; 5: 223–233.

9 Heesen C Reich C Borchers C Gold SM Schulz KH . Patient based scoring instruments in multiple sclerosis – German validation of the United Kingdom Disability Scale and the Patient Generated Index. Neurol Rehab 2007; 13: 24–36.

10.

10 Cutter GR Baier ML Rudick RA Cookfair DL Fischer JS Petkau J . Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999; 122: 871–882.

11.

11 Hoogervrost ELJ Eikelenboom MJ Uitdehaag BMJ Polman CH . One year change in disability in multiple sclerosis: neurological examination compared with patient self report. J Neurol Neurosurg Psychiatry 2003; 74: 439–442.

12.

12 De Groot V Beckerman H Uitdehaag BM de Vet HC Lankhorst GJ Polman CH . The usefulness of evaluative outcome measures in patients with multiple sclerosis. Brain 2006; 129: 2648–2659.